Vikas Sinha

CIK 1337845 · Chief Financial Officer · last filed 2026-04-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$27.39M

Companies

3

Total Filings

128

Lifetime Open-Market Net

-$4.66M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SRRK Chief Financial Officer 619,856 $44.18 $27.39M -$1.23M 5 2026-04-20
Verona Pharma plc (VRNA) Delisted Director 0 $106.91 $0 -$3.18M 12 2025-10-08
Kalaris Therapeutics, Inc. (ALVR) Delisted See Remarks 774,118 $9.81 $7.59M -$246.5K 40 2025-02-24

Recent Filings · Page 12 of 13

128 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2010-01-12 Sell (S) −2,861 -$136.4K
2009-12-14 Sell (S) −10,000 -$460.0K
2009-09-22 Sell (S) −1,833 -$84.8K
2009-07-17 Sell (S) −397 -$15.5K
2009-07-13 Sell (S) −318 -$11.7K
2009-03-25 Sell (S) −1,585 -$59.7K
2009-03-18 Sell (S) −2,357 -$80.7K
2009-01-28 Grant (A) +8,000 $0
2009-01-16 Sell (S) −1,661 -$61.2K
2009-01-14 Sell (S) −375 -$12.9K
Showing 111120 of 128
Page 12 of 13
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.